Investigation of carbon emissions due to COVID-19 vaccine inventory

被引:0
|
作者
Nita H. Shah
Ekta Patel
Kavita Rabari
机构
[1] Gujarat University,Department of Mathematics
关键词
Vaccine inventory; Quality inspection; Carbon emissions; Carbon tax; Spoilage of vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Inventory model for vaccine of COVID-19 pandemic is the subject of analysis in the proposed article. The initial registration for vaccination and vaccination of registered individuals is taken during the period under consideration. The paper considers the utility of vaccine during storage, holding cost, purchase cost, manufacturing cost and inspection cost. A fraction of registered individuals who do not turn up for a vaccination is taken into account. All the actions by the player incur carbon emissions. During the whole procedure of vaccination starting from raw material to end user carbon emissions are observed. Carbon emissions in stocking raw material, during inspection, during purchase activity, during set-up and transportation phase and holding it at point of delivery. Maximum carbon emission of 28% occur during purchase activity followed by 21% during transportation at the point of delivery and stocking it at respective places. To follow green policy, carbon tax is levied. A non-linear formulation of the proposed problem is modelled to compute optimum cycle time without allowing shortages. The convexity of the objective function is established through the numerical data. Analysis of carbon emissions and carbon tax levied is carried out through the data. Research Objective: Carbon Emission is one of a cause for ozone layer depletion. Moreover, it causes many ecological disturbances resulting into several environmental temperature variations. These all problem affect an individual’s health. So, there arise a need to frame a mathematical model to decipher relationship between COVID-19 vaccine inventory and effect of carbon emissions.
引用
收藏
页码:409 / 420
页数:11
相关论文
共 50 条
  • [31] COVID-19 vaccine and anaphylaxis
    Joob, B.
    Wiwanitkit, V.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2021, 205 (06): : 631 - 631
  • [32] COVID-19 vaccine dilemmas
    Lee, A. C. K.
    Morling, J. R.
    PUBLIC HEALTH, 2022, 202 : 10 - 11
  • [33] COVID-19 Vaccine Development
    Furman, Richard R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (04) : 195 - 195
  • [34] COVID-19 vaccine withdrawn
    Warren, Matthew
    SCIENCE, 2024, 384 (6697) : 719 - 719
  • [35] COVID-19 vaccine hesitancy
    Dube, Eve
    MacDonald, Noni E.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (07) : 409 - 410
  • [36] COVID-19 vaccine safety
    Amaro Hosey, Kristopher
    Quijada Manuitt, Maria Angeles
    Antoniajoan Arbos, Rosa
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 32 - 32
  • [37] Vaccine and COVID-19 Trajectories
    Choi, Kate H.
    Denice, Patrick A.
    Ramaj, Sagi
    SOCIUS, 2021, 7
  • [38] COVID-19: The race for a vaccine
    Lockey, Emily
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2020, 21 (02)
  • [39] The Russian vaccine for COVID-19
    Burki, Talha Khan
    LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : E85 - E86
  • [40] Race for a COVID-19 vaccine
    不详
    EBIOMEDICINE, 2020, 55